Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Cancer Research|February 21, 2006
Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivoKaren Blyth, François Vaillant, Linda Hanlon, et al.Blood Cells, Molecules & Diseases|March 10, 2009
Runx1 promotes B-cell survival and lymphoma developmentKaren Blyth, Nicholas Slater, Linda Hanlon, et al.Cancer Research|December 25, 2002
Feline immunodeficiency virus integration in B-cell lymphoma identifies a candidate tumor suppressor gene on human chromosome 15q15Julia Beatty, Anne Terry, Julie MacDonald, et al.The Journal of General Virology|March 22, 2002
Linkage on chromosome 10 of several murine retroviral integration loci associated with leukaemiaPeter Haviernik, Stephen M Festin, Rene Opavsky, et al.Journal of Cellular Biochemistry|July 2, 2019
Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activityJodie Hay, Kathryn Gilroy, Camille Huser, et al.Cancer Research|July 1, 2010
Runx regulation of sphingolipid metabolism and survival signalingAnna Kilbey, Anne Terry, Alma Jenkins, et al.Cancer Research|December 7, 2007
Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblastsAnna Kilbey, Karen Blyth, Sandy Wotton, et al.Journal of Virology|May 22, 2002
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulenceMargaret J Hosie, Brian J Willett, Dieter Klein, et al.Vaccine|October 20, 2006
Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virusStephen P Dunham, Jennifer Bruce, Dieter Klein, et al.Blood Cells, Molecules & Diseases|May 7, 2003
The Runx genes as dominant oncogenesEwan R Cameron, Karen Blyth, Linda Hanlon, et al.Pageof 4